- Featured Product
- KD/KO Validated
MYO18A Polyklonaler Antikörper
MYO18A Polyklonal Antikörper für IP, WB, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IP, IHC, IF, FC, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 14611-1-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | Jurkat-Zellen, HeLa-Zellen, K-562-Zellen, Neuro-2a-Zellen, NIH/3T3-Zellen |
Erfolgreiche IP | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 4 publications below |
WB | See 11 publications below |
IHC | See 1 publications below |
IF | See 5 publications below |
FC | See 1 publications below |
Produktinformation
14611-1-AP bindet in WB, IP, IHC, IF, FC, ELISA MYO18A und zeigt Reaktivität mit human, Maus, Ratten
Getestete Reaktivität | human, Maus, Ratte |
In Publikationen genannte Reaktivität | human, Maus, Ratte |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | MYO18A fusion protein Ag6185 |
Vollständiger Name | myosin XVIIIA |
Berechnetes Molekulargewicht | 233 kDa |
Beobachtetes Molekulargewicht | 230 kDa, 190 kDa |
GenBank-Zugangsnummer | BC039612 |
Gene symbol | MYO18A |
Gene ID (NCBI) | 399687 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
MYO18A is an unconventional myosin that may play a role in the stabilization and organization of the actin cytoskeleton. Recently MYO18A has been identified as the receptor of SP and is responsible for clearance of SP-A-opsonized bacteria in in vivo infection. Two different isoforms of mouse Myo18A have been identified: Myo18A-alpha and Myo18A-beta as 230- and 190-kDa proteins, respectively. Myo18a-alpha colocalizes with the ER-Golgi complex and with membrane ruffles and filopodia, while Myo18a-beta localizes diffusely to the cytoplasm.
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for MYO18A antibody 14611-1-AP | Protokoll herunterladen |
IHC protocol for MYO18A antibody 14611-1-AP | Protokoll herunterladen |
IP protocol for MYO18A antibody 14611-1-AP | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
J Clin Invest A pro-tumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma.
| ||
Cell Death Differ The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.
| ||
Cell Syst A Portrait of the Human Organelle Proteome In Space and Time during Cytomegalovirus Infection.
| ||
Oncoimmunology Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes. | ||
Diabetes Unbiased Profiling of the Human Proinsulin Biosynthetic Interaction Network Reveals a Role For Peroxiredoxin 4 in Proinsulin Folding. | ||
J Cell Sci Pushing myelination: developmental regulation of myosin expression drives oligodendrocyte morphological differentiation |